India’s pandemic turmoil hits emerging markets
India’s economy had been enjoying a strong recovery, driving optimistic forecasts for emerging markets. But then the latest wave of Covid-19 hit,

“India’s problem is the world’s problem”, says Yasmeen Serhan in The Atlantic. Just weeks ago, the country thought it had put the Covid-19 pandemic behind it. Then it reported more than a million new cases and over 8,000 deaths over a three-day period, setting grim new global records in the process. As the virus sweeps through developing countries “the world is on track to record more Covid-19 deaths this year than it did in 2020”.
Difficult months ahead
India’s tragedy has exposed a fragile medical system, says Michael Safi in The Guardian. It spends just 1% of GDP on its state healthcare service, one of the lowest figures in the world. The country was the world’s biggest vaccine producer heading into the pandemic but vaccinating 1.39 billion people is no easy task: less than 10% of the population has received a first shot.
Prime Minister Narendra Modi had boasted that the country had become the “world’s pharmacy”. India has exported 66 million vaccine doses since January even as its own health system has buckled, notes Hasit Shah for Quartz. Many low and middle-income countries were counting on deliveries of Indian-produced jabs that will now be delayed or diverted.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
India’s economy had been enjoying “a remarkably strong recovery” before the latest wave, says Capital Economics in a note. GDP is thought to have returned to pre-pandemic levels as early as the final quarter of last year and early data showed continued strong progress in the first three months of 2021. The International Monetary Fund had predicted a blistering 12.5% GDP growth rate for 2021. A strong Indian outlook helped drive optimistic forecasts for emerging markets, says Udith Sikand for Gavekal Research. Yet with the news from India growing ever worse, growth in developing countries (excluding China) is likely to undershoot that of developed markets this year.
More pressure on emerging markets
The benchmark BSE Sensex index has been broadly flat since the start of the year but has fallen by 7% since the middle of February. The rupee has slipped by 2.2% against the US dollar since the start of April, says Sikand. That makes it Asia’s worst-performing currency this quarter. International investors have been pulling back, reports Steve Goldstein for Barron’s. As of 23 April, foreign money managers had sold $814m of Indian stocks in April. The country is likely to see “net selling” of its assets for the first time in seven months.
The big worry in emerging markets had been that we were heading for “a repeat of 2013”, when spiking US bond yields sparked turmoil across world markets, says The Economist. In the event, the rise in US bond yields has cooled of late, giving countries such as Brazil, India and South Africa some financial respite. Instead, the new fear is that 2021 will turn out to be a depressing “repeat of last year”. Several Latin American countries are already experiencing second waves as bad as India’s. Many low-income countries are struggling to vaccinate their people. The grim scenes in India could yet be repeated elsewhere.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Pinewood Technologies: a drive for growth
Pinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'
Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with follies
The best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuation
AEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?
-
The Palace of Westminster is falling down
The Palace of Westminster is in need of repair, but the bill is prohibitive, says Simon Wilson
-
'It’s time to buy British equities'
Opinion There is no better place to start investing in UK equities than with two of MoneyWeek’s favourite investment trusts, says Max King